Pulmonx (LUNG) Invested Capital (2019 - 2025)

Pulmonx (LUNG) has reported Invested Capital for 7 consecutive years, with $91.3 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Invested Capital fell 27.62% year-over-year to $91.3 million in Q4 2025; TTM through Dec 2025 was $91.3 million, a 27.62% decrease from a year earlier, with the FY2025 full-year figure at $91.3 million, down 27.62% from the prior year.
• Invested Capital was $91.3 million for Q4 2025 at Pulmonx, down from $97.4 million in the prior quarter.
• Over five years, Invested Capital peaked at $250.3 million in Q1 2021 and troughed at $91.3 million in Q4 2025.
• A 5-year average of $167.7 million and a median of $167.3 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital surged 225.05% in 2021 and dropped 27.62% in 2025, its largest moves.
• Over 5 years, Invested Capital stood at $210.8 million in 2021, then declined by 18.69% to $171.4 million in 2022, then slipped by 8.0% to $157.7 million in 2023, then declined by 20.01% to $126.2 million in 2024, then decreased by 27.62% to $91.3 million in 2025.
• The last three Invested Capital figures came in at $91.3 million (Q4 2025), $97.4 million (Q3 2025), and $106.4 million (Q2 2025), per Business Quant data.